Found: 32
Select item for more details and to access through your institution.
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 6, p. 1, doi. 10.1093/jncics/pkab087
- By:
- Publication type:
- Article
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Socioeconomic Deprivation and Health Care Use in Patients Enrolled in SWOG Cancer Clinical Trials.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e244008, doi. 10.1001/jamanetworkopen.2024.4008
- By:
- Publication type:
- Article
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
- Published in:
- Prostate, 2017, v. 77, n. 8, p. 908, doi. 10.1002/pros.23346
- By:
- Publication type:
- Article
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
- Published in:
- Prostate, 2016, v. 76, n. 6, p. 565, doi. 10.1002/pros.23147
- By:
- Publication type:
- Article
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
- Published in:
- Prostate, 2015, v. 75, n. 13, p. 1403, doi. 10.1002/pros.23021
- By:
- Publication type:
- Article
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial.
- Published in:
- Prostate, 2010, v. 70, n. 6, p. 584, doi. 10.1002/pros.21092
- By:
- Publication type:
- Article
Response: Re: An Empirical Evaluation of Guidelines on Prostate-Specific Antigen Velocity in Prostate Cancer Detection.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 21, p. 1637, doi. 10.1093/jnci/djr355
- By:
- Publication type:
- Article
An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 6, p. 462, doi. 10.1093/jnci/djr028
- By:
- Publication type:
- Article
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 3, p. 603, doi. 10.1007/s10549-018-4946-0
- By:
- Publication type:
- Article
Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2234445, doi. 10.1001/jamanetworkopen.2022.34445
- By:
- Publication type:
- Article
Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. 1, doi. 10.1001/jamanetworkopen.2022.34445
- By:
- Publication type:
- Article
Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0126672
- By:
- Publication type:
- Article
Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims.
- Published in:
- Archives of Osteoporosis, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1007/s11657-019-0629-7
- By:
- Publication type:
- Article
Circadian genes and risk of prostate cancer in the prostate cancer prevention trial.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 3, p. 462, doi. 10.1002/mc.22770
- By:
- Publication type:
- Article
Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 455, doi. 10.1007/s10549-020-05634-1
- By:
- Publication type:
- Article
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 703, doi. 10.1093/jnci/djad053
- By:
- Publication type:
- Article
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.808715
- By:
- Publication type:
- Article
Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.
- Published in:
- International Journal of Cancer, 2009, v. 124, n. 9, p. 2082, doi. 10.1002/ijc.24144
- By:
- Publication type:
- Article
Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial.
- Published in:
- American Journal of Epidemiology, 2011, v. 173, n. 12, p. 1429, doi. 10.1093/aje/kwr027
- By:
- Publication type:
- Article
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
- Published in:
- Cancer Causes & Control, 2015, v. 26, n. 1, p. 35, doi. 10.1007/s10552-014-0480-5
- By:
- Publication type:
- Article
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
- Published in:
- Carcinogenesis, 2018, v. 39, n. 2, p. 125, doi. 10.1093/carcin/bgx144
- By:
- Publication type:
- Article
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 10, p. 1500, doi. 10.1093/carcin/bgr139
- By:
- Publication type:
- Article